| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix binding | 6.87e-05 | 73 | 60 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | heparin binding | 2.78e-04 | 192 | 60 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 7.81e-04 | 60 | 60 | 3 | GO:0005544 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.25e-03 | 268 | 60 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipase A2 activity | 1.32e-03 | 18 | 60 | 2 | GO:0047498 | |
| GeneOntologyMolecularFunction | phospholipase A1 activity | 1.47e-03 | 19 | 60 | 2 | GO:0008970 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.72e-03 | 749 | 60 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | interleukin-1 receptor binding | 1.80e-03 | 21 | 60 | 2 | GO:0005149 | |
| GeneOntologyMolecularFunction | collagen binding | 1.86e-03 | 81 | 60 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | transaminase activity | 2.75e-03 | 26 | 60 | 2 | GO:0008483 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.83e-03 | 323 | 60 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | transferase activity, transferring nitrogenous groups | 3.19e-03 | 28 | 60 | 2 | GO:0016769 | |
| GeneOntologyCellularComponent | extracellular matrix | SLIT2 LRIG3 HSPG2 DST COL6A6 COL20A1 ANGPTL3 ADAMTS15 RPSA NYX | 2.13e-05 | 656 | 62 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SLIT2 LRIG3 HSPG2 DST COL6A6 COL20A1 ANGPTL3 ADAMTS15 RPSA NYX | 2.19e-05 | 658 | 62 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.64e-04 | 530 | 62 | 8 | GO:0062023 | |
| Domain | Cys-rich_flank_reg_C | 3.88e-07 | 90 | 59 | 6 | IPR000483 | |
| Domain | LRRCT | 3.88e-07 | 90 | 59 | 6 | SM00082 | |
| Domain | LRR_1 | 4.17e-07 | 219 | 59 | 8 | PF00560 | |
| Domain | LRR_8 | 1.09e-06 | 171 | 59 | 7 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.37e-06 | 177 | 59 | 7 | IPR003591 | |
| Domain | LRR_TYP | 1.37e-06 | 177 | 59 | 7 | SM00369 | |
| Domain | Leu-rich_rpt | 2.07e-06 | 271 | 59 | 8 | IPR001611 | |
| Domain | LRRCT | 3.02e-06 | 32 | 59 | 4 | PF01463 | |
| Domain | LRR | 3.20e-06 | 201 | 59 | 7 | PS51450 | |
| Domain | Laminin_G_1 | 4.85e-06 | 11 | 59 | 3 | PF00054 | |
| Domain | - | 7.22e-06 | 321 | 59 | 8 | 3.80.10.10 | |
| Domain | L_dom-like | 8.45e-06 | 328 | 59 | 8 | IPR032675 | |
| Domain | LRRNT | 1.44e-05 | 98 | 59 | 5 | IPR000372 | |
| Domain | LRRNT | 1.44e-05 | 98 | 59 | 5 | SM00013 | |
| Domain | Laminin_G | 3.35e-05 | 58 | 59 | 4 | IPR001791 | |
| Domain | LysoPLipase_cat_dom | 2.04e-04 | 7 | 59 | 2 | IPR002642 | |
| Domain | PLA2_B | 2.04e-04 | 7 | 59 | 2 | PF01735 | |
| Domain | PLA2C | 2.04e-04 | 7 | 59 | 2 | PS51210 | |
| Domain | PLAc | 2.04e-04 | 7 | 59 | 2 | SM00022 | |
| Domain | LAM_G_DOMAIN | 2.33e-04 | 38 | 59 | 3 | PS50025 | |
| Domain | LamG | 3.62e-04 | 44 | 59 | 3 | SM00282 | |
| Domain | LRRNT | 6.27e-04 | 53 | 59 | 3 | PF01462 | |
| Domain | ConA-like_dom | 6.34e-04 | 219 | 59 | 5 | IPR013320 | |
| Domain | Acyl_Trfase/lysoPLipase | 1.29e-03 | 17 | 59 | 2 | IPR016035 | |
| Domain | PWWP | 1.80e-03 | 20 | 59 | 2 | SM00293 | |
| Domain | PWWP | 2.38e-03 | 23 | 59 | 2 | PF00855 | |
| Domain | PWWP_dom | 2.38e-03 | 23 | 59 | 2 | IPR000313 | |
| Domain | Collagen | 2.46e-03 | 85 | 59 | 3 | IPR008160 | |
| Domain | Collagen | 2.46e-03 | 85 | 59 | 3 | PF01391 | |
| Domain | PWWP | 2.59e-03 | 24 | 59 | 2 | PS50812 | |
| Domain | - | 3.37e-03 | 95 | 59 | 3 | 2.60.120.200 | |
| Domain | - | 5.46e-03 | 35 | 59 | 2 | 3.90.1150.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 5.77e-03 | 36 | 59 | 2 | IPR015422 | |
| Pubmed | 1.67e-06 | 202 | 62 | 6 | 24639526 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 URB1 DST NISCH NSD1 RPSA BTAF1 HERC1 LYST IQGAP3 PLXNA1 | 3.65e-06 | 1105 | 62 | 11 | 35748872 |
| Pubmed | 3.90e-06 | 234 | 62 | 6 | 36243803 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 8660987 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 24459426 | ||
| Pubmed | Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis. | 1.87e-05 | 4 | 62 | 2 | 28459195 | |
| Pubmed | 2.05e-05 | 653 | 62 | 8 | 22586326 | ||
| Pubmed | 2.63e-05 | 195 | 62 | 5 | 19454010 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.11e-05 | 202 | 62 | 5 | 33005030 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 15866882 | ||
| Pubmed | 3.56e-05 | 513 | 62 | 7 | 25798074 | ||
| Pubmed | 3.97e-05 | 106 | 62 | 4 | 12429849 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 14557068 | ||
| Pubmed | Scara5 is a ferritin receptor mediating non-transferrin iron delivery. | 4.67e-05 | 6 | 62 | 2 | 19154717 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 14550773 | ||
| Pubmed | Differential expression of Slitrk family members in the mouse nervous system. | 4.67e-05 | 6 | 62 | 2 | 19924824 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 8.03e-05 | 1024 | 62 | 9 | 24711643 | |
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 8.69e-05 | 8 | 62 | 2 | 25485759 | |
| Pubmed | 1.38e-04 | 277 | 62 | 5 | 30745168 | ||
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 1.63e-04 | 59 | 62 | 3 | 28813667 | |
| Pubmed | ILF3 DST COL20A1 PCLO SCN4A TENM1 PLA2G4D CCDC191 LYST DNMT3B | 2.19e-04 | 1442 | 62 | 10 | 35575683 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 2.61e-04 | 498 | 62 | 6 | 36634849 | |
| Pubmed | 2.78e-04 | 504 | 62 | 6 | 34432599 | ||
| Pubmed | 2.81e-04 | 14 | 62 | 2 | 8631027 | ||
| Pubmed | Dystroglycan organizes axon guidance cue localization and axonal pathfinding. | 2.81e-04 | 14 | 62 | 2 | 23217742 | |
| Pubmed | 2.81e-04 | 14 | 62 | 2 | 26912663 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 3.00e-04 | 724 | 62 | 7 | 36232890 | |
| Pubmed | 3.19e-04 | 332 | 62 | 5 | 37433992 | ||
| Pubmed | Cas adaptor proteins organize the retinal ganglion cell layer downstream of integrin signaling. | 3.23e-04 | 15 | 62 | 2 | 24559672 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 3.31e-04 | 736 | 62 | 7 | 29676528 | |
| Pubmed | 3.69e-04 | 16 | 62 | 2 | 24292684 | ||
| Pubmed | 4.04e-04 | 1006 | 62 | 8 | 15226823 | ||
| Pubmed | 4.18e-04 | 17 | 62 | 2 | 26102480 | ||
| Pubmed | 4.38e-04 | 549 | 62 | 6 | 38280479 | ||
| Pubmed | 5.10e-04 | 206 | 62 | 4 | 22174317 | ||
| Pubmed | 5.24e-04 | 19 | 62 | 2 | 21508241 | ||
| Pubmed | PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. | 5.67e-04 | 90 | 62 | 3 | 30699358 | |
| Pubmed | 5.98e-04 | 215 | 62 | 4 | 30462309 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 6.63e-04 | 221 | 62 | 4 | 29991511 | |
| Pubmed | 7.06e-04 | 22 | 62 | 2 | 38736483 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 7.21e-04 | 226 | 62 | 4 | 25900982 | |
| Pubmed | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | 8.64e-04 | 104 | 62 | 3 | 26167872 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 9.09e-04 | 1425 | 62 | 9 | 30948266 | |
| Pubmed | 1.07e-03 | 27 | 62 | 2 | 25843547 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.13e-03 | 440 | 62 | 5 | 34244565 | |
| Pubmed | 1.15e-03 | 28 | 62 | 2 | 18617019 | ||
| Pubmed | Maternal DNA Methylation Regulates Early Trophoblast Development. | 1.15e-03 | 28 | 62 | 2 | 26812015 | |
| Pubmed | 1.21e-03 | 117 | 62 | 3 | 17145500 | ||
| Pubmed | 1.26e-03 | 263 | 62 | 4 | 34702444 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 1.28e-03 | 1496 | 62 | 9 | 32877691 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.34e-03 | 934 | 62 | 7 | 33916271 | |
| Pubmed | 1.41e-03 | 31 | 62 | 2 | 37816598 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 1.47e-03 | 949 | 62 | 7 | 36574265 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.51e-03 | 954 | 62 | 7 | 36373674 | |
| Pubmed | 1.59e-03 | 33 | 62 | 2 | 34841685 | ||
| Pubmed | 1.62e-03 | 707 | 62 | 6 | 19738201 | ||
| Pubmed | 1.67e-03 | 971 | 62 | 7 | 33306668 | ||
| Pubmed | 1.71e-03 | 483 | 62 | 5 | 36912080 | ||
| Pubmed | 1.72e-03 | 484 | 62 | 5 | 31995728 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.76e-03 | 486 | 62 | 5 | 30940648 | |
| Cytoband | 15q15.1 | 1.87e-03 | 47 | 62 | 2 | 15q15.1 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 6.82e-04 | 19 | 37 | 2 | 832 | |
| GeneFamily | PWWP domain containing | 9.17e-04 | 22 | 37 | 2 | 1147 | |
| GeneFamily | Phospholipases | 3.33e-03 | 42 | 37 | 2 | 467 | |
| GeneFamily | Collagens | 3.99e-03 | 46 | 37 | 2 | 490 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 2.94e-06 | 268 | 61 | 7 | M45696 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 6.97e-06 | 199 | 61 | 6 | M7254 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-08 | 196 | 62 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.81e-07 | 192 | 62 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-07 | 193 | 62 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-07 | 195 | 62 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.08e-07 | 195 | 62 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.18e-07 | 196 | 62 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.37e-07 | 198 | 62 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.47e-07 | 199 | 62 | 6 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.47e-07 | 199 | 62 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-07 | 200 | 62 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-07 | 200 | 62 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-07 | 200 | 62 | 6 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.58e-07 | 200 | 62 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.71e-07 | 125 | 62 | 5 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | HSPCs-Ery/Mk_prog.|World / Lineage and Cell class | 6.44e-06 | 188 | 62 | 5 | 5390089213cd6ee90dcdfd3c3f5b6765376cccf2 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 6.44e-06 | 188 | 62 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.44e-06 | 188 | 62 | 5 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.78e-06 | 190 | 62 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.78e-06 | 190 | 62 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.96e-06 | 191 | 62 | 5 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-06 | 191 | 62 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.96e-06 | 191 | 62 | 5 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.96e-06 | 191 | 62 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.14e-06 | 192 | 62 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.14e-06 | 192 | 62 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.32e-06 | 193 | 62 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.50e-06 | 194 | 62 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.69e-06 | 195 | 62 | 5 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.69e-06 | 195 | 62 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-06 | 195 | 62 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.28e-06 | 198 | 62 | 5 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 8.28e-06 | 198 | 62 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.28e-06 | 198 | 62 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.28e-06 | 198 | 62 | 5 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 8.49e-06 | 199 | 62 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.49e-06 | 199 | 62 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.49e-06 | 199 | 62 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.70e-06 | 200 | 62 | 5 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.13e-05 | 146 | 62 | 4 | a317f14a1aab11ffcce65baeb1c475c04324315f | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.44e-05 | 166 | 62 | 4 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 167 | 62 | 4 | 69caf4a53805f8c104d7dd8f88665fc992e23720 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-05 | 167 | 62 | 4 | 589c0acfeb4d70931b6726fb3331d85a54e74d56 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 9.04e-05 | 169 | 62 | 4 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.01e-04 | 174 | 62 | 4 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.01e-04 | 174 | 62 | 4 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.01e-04 | 174 | 62 | 4 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.01e-04 | 174 | 62 | 4 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 174 | 62 | 4 | 68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 175 | 62 | 4 | 2dcb5145835c3872d0f92f3ece23730cf65487bd | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 175 | 62 | 4 | 3c3cbaeec6ef2f61e6b177c95b999752c2d83ddb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 175 | 62 | 4 | 1d1984a03d0f04cd06048ed62d123033af364e82 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.06e-04 | 176 | 62 | 4 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 177 | 62 | 4 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 177 | 62 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.08e-04 | 177 | 62 | 4 | f7a2e6b5e82f0565f8030696944f33c544233b94 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 177 | 62 | 4 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.08e-04 | 177 | 62 | 4 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.08e-04 | 177 | 62 | 4 | ef02ee75db36a92dda889efb6fad1193efbc4be4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 177 | 62 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-04 | 177 | 62 | 4 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 177 | 62 | 4 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 177 | 62 | 4 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 178 | 62 | 4 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 178 | 62 | 4 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.13e-04 | 179 | 62 | 4 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.15e-04 | 180 | 62 | 4 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.15e-04 | 180 | 62 | 4 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-04 | 181 | 62 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 183 | 62 | 4 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.23e-04 | 183 | 62 | 4 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.25e-04 | 184 | 62 | 4 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-04 | 184 | 62 | 4 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 185 | 62 | 4 | 2c1f14f77faeee2acb388d997c5a27a7fef79be1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.28e-04 | 185 | 62 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 185 | 62 | 4 | 37db8e0b1f59274227f6fc2362167eb44bd080ef | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 185 | 62 | 4 | e0c9e92e35fb24351f5347a0768e6aab5add8775 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 185 | 62 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 186 | 62 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.34e-04 | 187 | 62 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 62 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 187 | 62 | 4 | 7beba2a5d5978f2ae7d8bde10815705cf2572211 | |
| ToppCell | 15-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 1.34e-04 | 187 | 62 | 4 | a7d2f30fe0f19e63d44603ece9890acd11b45e52 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 62 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 533685a921a65d84107d8d33c43b4fffde019143 | |
| Disease | level of thioredoxin-like protein 4A in blood serum | 1.18e-05 | 3 | 59 | 2 | OBA_2043972 | |
| Disease | level of inositol monophosphatase 1 in blood serum | 1.18e-05 | 3 | 59 | 2 | OBA_2042021 | |
| Disease | cilia- and flagella-associated protein 45 measurement | 1.18e-05 | 3 | 59 | 2 | EFO_0802401 | |
| Disease | cytochrome c oxidase subunit 8A, mitochondrial measurement | 1.18e-05 | 3 | 59 | 2 | EFO_0801516 | |
| Disease | level of alpha-aminoadipic semialdehyde dehydrogenase in blood serum | 1.18e-05 | 3 | 59 | 2 | OBA_2040566 | |
| Disease | level of colipase-like protein 1 in blood serum | 1.18e-05 | 3 | 59 | 2 | OBA_2044720 | |
| Disease | level of serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform in blood serum | 1.18e-05 | 3 | 59 | 2 | OBA_2043011 | |
| Disease | level of cellular tumor antigen p53 in blood serum | 1.18e-05 | 3 | 59 | 2 | OBA_2040413 | |
| Disease | signal-transducing adaptor protein 1 measurement | 2.35e-05 | 4 | 59 | 2 | EFO_0803075 | |
| Disease | bactericidal permeability-increasing protein measurement | 3.92e-05 | 5 | 59 | 2 | EFO_0020172 | |
| Disease | acidic leucine-rich nuclear phosphoprotein 32 family member A measurement | 3.92e-05 | 5 | 59 | 2 | EFO_0802250 | |
| Disease | lipopolysaccharide-binding protein measurement | 5.87e-05 | 6 | 59 | 2 | EFO_0021894 | |
| Disease | intercellular adhesion molecule 2 measurement | 5.87e-05 | 6 | 59 | 2 | EFO_0008163 | |
| Disease | keratinocyte differentiation-associated protein measurement | 8.20e-05 | 7 | 59 | 2 | EFO_0801743 | |
| Disease | heterogeneous nuclear ribonucleoproteins C1/C2 measurement | 8.20e-05 | 7 | 59 | 2 | EFO_0801675 | |
| Disease | CD226 antigen measurement | 8.20e-05 | 7 | 59 | 2 | EFO_0020246 | |
| Disease | chitinase-3-like protein 2 measurement | 1.09e-04 | 8 | 59 | 2 | EFO_0801471 | |
| Disease | mitochondrial ubiquitin ligase activator of NFKB 1 measurement | 1.40e-04 | 9 | 59 | 2 | EFO_0801804 | |
| Disease | transcription factor IIIb 90 kda subunit measurement | 1.75e-04 | 10 | 59 | 2 | EFO_0020778 | |
| Disease | PR domain zinc finger protein 1 measurement | 2.14e-04 | 11 | 59 | 2 | EFO_0801904 | |
| Disease | RAC-beta serine/threonine-protein kinase measurement | 3.02e-04 | 13 | 59 | 2 | EFO_0021989 | |
| Disease | Neoplasm Invasiveness | 5.10e-04 | 184 | 59 | 4 | C0027626 | |
| Disease | dermatomyositis (is_marker_for) | 5.24e-04 | 17 | 59 | 2 | DOID:10223 (is_marker_for) | |
| Disease | syndrome (implicated_via_orthology) | 5.89e-04 | 18 | 59 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Metabolic Syndrome X | 8.05e-04 | 21 | 59 | 2 | C0524620 | |
| Disease | HDL cholesterol change measurement | 1.05e-03 | 24 | 59 | 2 | EFO_0007805 | |
| Disease | lifestyle measurement | 1.27e-03 | 235 | 59 | 4 | EFO_0010724 | |
| Disease | excessive daytime sleepiness measurement | 1.99e-03 | 33 | 59 | 2 | EFO_0007875 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLVALGLFSQHFNLA | 276 | Q9UBC3 | |
| LGHNGAGKSTLLNIL | 426 | Q8WWZ4 | |
| KQLASFLHGNASLLF | 591 | P56945 | |
| QASLALLFGKHSQAI | 81 | Q8NHS2 | |
| LGLLALQHFELANSL | 236 | B1ANY3 | |
| LANGLLQLGHGLKDF | 46 | Q9Y5C1 | |
| LLLSLFLLGGQAQHV | 6 | P23280 | |
| LALKNSQGKYLLNGH | 726 | Q8TE58 | |
| QGGALSRHAKKLFLA | 591 | Q13367 | |
| GALQARLGALHKALK | 171 | Q9UPQ7 | |
| SLIKGGAANQALLHS | 766 | Q96L73 | |
| GKSQGLNLHTLLYLG | 4041 | P98160 | |
| QDLKSFHLVGLGATL | 956 | Q7RTW8 | |
| ARLIAHAGSLLNLAK | 296 | Q9Y2X3 | |
| LGLQIHKDFLFLGAN | 461 | P18428 | |
| FLGLSLLNTLHIGNN | 331 | Q6UXM1 | |
| KLEGALLALGQFQHA | 6371 | Q03001 | |
| KLNQALLDLHALGSA | 106 | P02792 | |
| NNAAHAGKALLTGLL | 406 | P80404 | |
| KLLSNHLALALAGGV | 796 | Q15751 | |
| GLLSLLNDFHSGKLQ | 181 | Q8IWP9 | |
| AGHSLQILLFSNGGK | 5091 | Q9Y6V0 | |
| HGLGSTDNVNKLLLL | 106 | Q9UIW2 | |
| TLHEFKTLLGLQGLN | 36 | O95843 | |
| KLQYHAGLASGLLNQ | 116 | Q6P2C8 | |
| GNLGLIILFGLNSHL | 41 | Q8NGG8 | |
| SLRNGVLLAKLGHCF | 61 | Q86VI3 | |
| AAQSALLLGIGLQHK | 861 | Q9H0A0 | |
| LKVLYLHNNQLLAGG | 16 | Q9UBH0 | |
| KHAKLDFLNNLATGL | 111 | Q92982 | |
| GHLLGLQKLNLLDCA | 391 | Q3MJ16 | |
| ALSKHRGINQALGAL | 241 | Q9H6J7 | |
| GQLLLFHLNSKSALQ | 711 | O14981 | |
| HSVLDFLQLGALAGL | 336 | Q9P218 | |
| LLQAASLGKLSANGL | 436 | Q8NCU4 | |
| ALRLAAFGQLHKVLG | 321 | Q12906 | |
| LFLLSLLFLVQGAHG | 11 | Q9Y653 | |
| LVHGRGFLLLTKLNS | 46 | Q99698 | |
| NLKLLDLSGNNLTHL | 171 | P40197 | |
| GDVLSLHLLQLAFGN | 296 | Q8WYP5 | |
| HFGLLLLLSQQAKNG | 36 | Q6ZN92 | |
| KAAGFQLSSHLLQLI | 621 | O14815 | |
| TSQLLGAKAFAQLHG | 1746 | D6RIA3 | |
| QLGSLSALKHAVLGL | 51 | Q6ZMJ2 | |
| LKQLLSFALGGLLGN | 106 | Q96H72 | |
| LNHLRKNFGFIGGSL | 91 | A6NMZ7 | |
| FLLLGFSHLADLQGL | 11 | Q96KK4 | |
| TSLYGHLLALQKLGL | 336 | Q86XP0 | |
| GAFQNLSGLLALHLN | 296 | Q9GZU5 | |
| LKFLAAGTHLGGTNL | 16 | P08865 | |
| GAFLGLSALKQLHLN | 101 | Q8IW52 | |
| LGIGFAKAFLLGLLH | 831 | P35499 | |
| GAFNGLGLLKQLHIN | 106 | Q9H5Y7 | |
| LKQAAGSGHLLALGT | 256 | P04278 | |
| LNGNINLLSHGKSAR | 2176 | Q9UKZ4 | |
| LLLAAAGKSAQLGLH | 216 | P03915 | |
| GNLTLLHFLLGLKTA | 336 | O60287 | |
| LHLLLSHLLFGQKGA | 181 | A5YKK6 | |
| LLAVLGEQHSGKSFL | 171 | Q9ULX5 | |
| LGLGNLTHLSLKYNN | 196 | Q9NR96 | |
| NNILSNLGHVLLGFL | 496 | Q9NXL6 | |
| NLAGNLLESLSGLHK | 361 | Q9Y2I1 | |
| FDGLKSLRLLSLHGN | 821 | O94813 | |
| GKLLRTGLNALHQAV | 6 | Q9H6R7 |